Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ
· Real-Time Price · USD
1.69
0.03 (1.81%)
At close: Sep 03, 2025, 3:59 PM
1.81% (1D)
| Bid | 1.67 |
| Market Cap | 7.74M |
| Revenue (ttm) | 893.99K |
| Net Income (ttm) | -21.65M |
| EPS (ttm) | -22.36 |
| PE Ratio (ttm) | -0.08 |
| Forward PE | -0.9 |
| Analyst | Hold |
| Ask | 1.7 |
| Volume | 986 |
| Avg. Volume (20D) | 155,309 |
| Open | 1.69 |
| Previous Close | 1.66 |
| Day's Range | 1.69 - 1.69 |
| 52-Week Range | 0.18 - 8.20 |
| Beta | 0.25 |
About MYNZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MYNZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MYNZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+17.01%
Mainz Biomed shares are trading higher after the c...
Unlock content with
Pro Subscription
4 months ago
+4.82%
Mainz Biomed shares are trading higher after the company announced its Q1 corporate update and path to FDA premarket approval.
